# Aster DM Healthcare Q1 EBITDA up 28%, broker maintains buy 2026-08-07T15:06:28+00:00 | Business & Economy | Indian Opinion Desk Corroboration: 1 independent outlet Aster DM Healthcare reported a 28% year-on-year rise in consolidated EBITDA for Q1FY27 to Rs 270 crore, beating estimates by 8%, thehindubusinessline.com reports citing a broker note. Revenue rose 22% to Rs 1,310 crore, also 6% above estimates. Occupancy improved 300 basis points to 62%, while total patient volumes grew 16% to 1.03 million. The newly-commercialised greenfield hospital in Kasargod achieved EBITDA breakeven in Q1, compared to a loss of Rs 8 crore in Q4FY26. Aster completed its merger with Quality Care India Ltd (QCIL) effective Q2FY27, making it the third-largest healthcare chain in India by revenue and bed capacity. The combined entity has net debt of Rs 1,160 crore. The broker maintains a 'Buy' rating with a revised target price of Rs 920. ## Coverage - thehindubusinessline.com Tags: Aster DM Healthcare, Ebitda, healthcare, merger, Q1 results, stock rating Canonical: https://indianopinion.org/aster-dm-healthcare-q1-ebitda-up-28-broker-maintains-buy/ License: Summary and commentary (c) Indian Opinion, reusable with attribution. Facts belong to the linked sources. Cite: https://indianopinion.org/aster-dm-healthcare-q1-ebitda-up-28-broker-maintains-buy/#story-in-brief Review state: restored archive article, accurate at time of publication, not offered to search indexes.